Nurix Therapeutics Inc. (NRIX) Social Stream
NURIX THERAPEUTICS INC (NRIX) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering NURIX THERAPEUTICS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-30 | 8 | $64 | $42 | $50.285 | $9.34 | 438.38% |
| 2021-12-29 | 8 | $64 | $42 | $51.75 | $9.34 | 454.07% |
| 2022-01-28 | 8 | $64 | $42 | $52.857 | $9.34 | 465.92% |
| 2022-01-31 | 8 | $64 | $42 | $51.571 | $9.34 | 452.15% |
| 2022-02-08 | 8 | $62 | $37 | $47.714 | $9.34 | 410.86% |
| 2022-04-07 | 9 | $62 | $28 | $45.25 | $9.34 | 384.48% |
| 2022-04-13 | 9 | $62 | $28 | $44.857 | $9.34 | 380.27% |
| 2022-04-28 | 6 | $60 | $28 | $45 | $9.34 | 381.8% |
| 2022-05-22 | 6 | $60 | $25 | $44.5 | $9.34 | 376.45% |
| 2022-05-31 | 7 | $60 | $25 | $40.714 | $9.34 | 335.91% |
| 2022-10-07 | 8 | $54 | $25 | $36.125 | $9.34 | 286.78% |
| 2022-10-11 | 9 | $53 | $11 | $33.222 | $9.34 | 255.7% |
| 2023-02-07 | 9 | $53 | $11 | $32.222 | $9.34 | 244.99% |
| 2023-02-12 | 10 | $53 | $11 | $31.9 | $9.34 | 241.54% |
| 2023-02-14 | 10 | $53 | $11 | $31.3 | $9.34 | 235.12% |
| 2023-02-24 | 10 | $53 | $11 | $31.2 | $9.34 | 234.05% |
| 2023-02-28 | 11 | $53 | $11 | $30.636 | $9.34 | 228.01% |
| 2023-03-09 | 12 | $53 | $11 | $29.75 | $9.34 | 218.52% |
The Trend in the Analyst Price Target
NRIX's average price target has moved down $10.96 over the prior 40 weeks.
NRIX reports an average of 240.72% for its upside potential over the past 48 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-04-14 | 7 | 60 | 28 | 44.571 | 13.70 | 225.34% |
| 2022-04-28 | 6 | 60 | 28 | 45.000 | 11.30 | 298.23% |
| 2022-07-12 | 8 | 54 | 25 | 36.125 | 15.97 | 126.21% |
| 2023-02-28 | 11 | 53 | 11 | 30.636 | 9.43 | 224.88% |
| 2023-03-09 | 12 | 53 | 11 | 29.750 | 9.07 | 228% |
NRIX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.33 | 9 | 2 | 1 | 0 | 0 | 12 |
The Trend in the Broker Recommendations
Over the past 48 weeks, NRIX's average broker recommendation rating improved by 0.05.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for NRIX as an investment opportunity.
- NRIX has a higher upside potential (average analyst target price relative to current price) than 2399.36% of all US stocks.
- NURIX THERAPEUTICS INC's variance in analysts' estimates is lower than -2025.21% of all US stocks.
- NURIX THERAPEUTICS INC's number of analysts covering the stock is greater than 2481.89% of stocks in the small market cap category.
- To contextualize these metrics, consider that out of stocks in the small market cap category, NURIX THERAPEUTICS INC's average analyst price target is higher than 2226.26% of them.
In the Pharmaceutical Products industry, INZY, TNGX, and DYN are the three stocks most similar to NURIX THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is NRIX a Buy, Hold or Sell? See the POWR Ratings now!